These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


652 related items for PubMed ID: 29695348

  • 1. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R, Strnad V, Polgár C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Gall C, Polat B, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [Abstract] [Full Text] [Related]

  • 2. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [Abstract] [Full Text] [Related]

  • 3. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.
    Strnad V, Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Łyczek J, Guinot JL, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Fietkau R, Schlamann A, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Dunst J, Gall C, Uter W, Groupe Européen de Curiethérapie and European Society for Radiotherapy and Oncology.
    Lancet Oncol; 2023 Mar; 24(3):262-272. PubMed ID: 36738756
    [Abstract] [Full Text] [Related]

  • 4. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
    Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).
    Lancet; 2016 Jan 16; 387(10015):229-38. PubMed ID: 26494415
    [Abstract] [Full Text] [Related]

  • 5. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
    Meattini I, Saieva C, Miccinesi G, Desideri I, Francolini G, Scotti V, Marrazzo L, Pallotta S, Meacci F, Muntoni C, Bendinelli B, Sanchez LJ, Bernini M, Orzalesi L, Nori J, Bianchi S, Livi L.
    Eur J Cancer; 2017 May 16; 76():17-26. PubMed ID: 28262584
    [Abstract] [Full Text] [Related]

  • 6. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
    Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, Kuske RR, Ganz PA, Parda DS, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, McCormick B, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ, Bryant JL, Wolmark N.
    Lancet; 2019 Dec 14; 394(10215):2155-2164. PubMed ID: 31813636
    [Abstract] [Full Text] [Related]

  • 7. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
    Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, Olivotto IA, RAPID Trial Investigators.
    Lancet; 2019 Dec 14; 394(10215):2165-2172. PubMed ID: 31813635
    [Abstract] [Full Text] [Related]

  • 8. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH, BIG 3-07/TROG 07.01 trial investigators.
    Lancet Oncol; 2020 May 14; 21(5):685-698. PubMed ID: 32203696
    [Abstract] [Full Text] [Related]

  • 9. GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.
    Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Łyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Kortmann RD, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).
    Radiother Oncol; 2016 Jul 14; 120(1):119-23. PubMed ID: 27422584
    [Abstract] [Full Text] [Related]

  • 10. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
    Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS, MRC SUPREMO trial UK investigators.
    Lancet Oncol; 2018 Nov 14; 19(11):1516-1529. PubMed ID: 30337220
    [Abstract] [Full Text] [Related]

  • 11. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan D, Dubois JB, Remouchamps V, Mirimanoff RO, Collette S, Collette L, European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.
    Lancet Oncol; 2015 Jan 14; 16(1):47-56. PubMed ID: 25500422
    [Abstract] [Full Text] [Related]

  • 12. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
    Manyam BV, Tendulkar R, Cherian S, Vicini F, Badiyan SN, Shah C.
    Am J Clin Oncol; 2018 Jun 14; 41(6):526-531. PubMed ID: 27635622
    [Abstract] [Full Text] [Related]

  • 13. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C, Major T, Fodor J, Németh G, Orosz Z, Sulyok Z, Udvarhelyi N, Somogyi A, Takácsi-Nagy Z, Lövey K, Agoston P, Kásler M.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1173-81. PubMed ID: 15519789
    [Abstract] [Full Text] [Related]

  • 14. Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation.
    Cambeiro M, Martinez-Regueira F, Rodriguez-Spiteri N, Olartecoechea B, Insausti LP, Elizalde A, Gastearena MI, Gallego JS, Santisteban M, Aramendía JM, Aristu JJ, Moreno LA, Moreno-Jiménez M, Valtueña G, Martínez-Monge R.
    Brachytherapy; 2016 Nov 15; 15(4):485-494. PubMed ID: 27129410
    [Abstract] [Full Text] [Related]

  • 15. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Strnad V, Major T, Polgar C, Lotter M, Guinot JL, Gutierrez-Miguelez C, Galalae R, Van Limbergen E, Guix B, Niehoff P, Lössl K, Hannoun-Levi JM.
    Radiother Oncol; 2018 Sep 15; 128(3):411-420. PubMed ID: 29691075
    [Abstract] [Full Text] [Related]

  • 16. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
    Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM, PRIME II investigators.
    Lancet Oncol; 2015 Mar 15; 16(3):266-73. PubMed ID: 25637340
    [Abstract] [Full Text] [Related]

  • 17. Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial.
    Hannoun-Levi JM, Chamorey E, Boulahssass R, Polgar C, Strnad V, Breast Cancer Working Group of the GEC-ESTRO.
    Clin Transl Radiat Oncol; 2021 Jul 15; 29():1-8. PubMed ID: 33997321
    [Abstract] [Full Text] [Related]

  • 18. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.
    Garsa AA, Ferraro DJ, DeWees TA, Deshields TL, Margenthaler JA, Cyr AE, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Ochoa LL, Zoberi I.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1043-50. PubMed ID: 24161428
    [Abstract] [Full Text] [Related]

  • 19. Accelerated partial breast irradiation for elderly women with early breast cancer: A compromise between whole breast irradiation and omission of radiotherapy.
    Sumodhee S, Levy J, Chamorey E, Lam Cham Kee D, Chand ME, Gautier M, Peyrottes I, Barranger E, Hannoun-Levi JM.
    Brachytherapy; 2017 Dec 01; 16(5):929-934. PubMed ID: 28697858
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
    Gabani P, Cyr AE, Zoberi JE, Ochoa LL, Matesa MA, Thomas MA, Garcia J, Margenthaler JA, Naughton MJ, Ma C, Sanati S, Zoberi I.
    Brachytherapy; 2018 Dec 01; 17(1):171-180. PubMed ID: 29089275
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.